|
|
||||||||


Divisions of
*
Vascular Surgery and
Respiratory Diseases, Max Bell Research Center, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada;
Division of Cell Biology, Sick Childrens Hospital, Toronto, Ontario, Canada; and
§
Department of Biochemistry and Molecular Biology, St. Louis University Health Sciences Center, St. Louis, MO 63104
The purpose of this study was to define the role of secretory phospholipase A2 (sPLA2), calcium-independent PLA2, and cytosolic PLA2 (cPLA2) in arachidonic acid (AA) release from fMLP-stimulated human neutrophils. While fMLP induced the release of extracellular sPLA2 activity and AA, 70% of sPLA2 activity remained associated with the cell. Treatment with the cell-impermeable sPLA2 inhibitors DTT or LY311-727, or the anti-sPLA2 Ab 3F10 all inactivated extracellular sPLA2 activity, but had minimal effect on neutrophil AA mass release. In contrast, coincubation of streptolysin-O toxin-permeabilized neutrophils with DTT, LY311-727, or 3F10 all decreased [3H8]AA release from [3H8]AA-labeled, fMLP-stimulated cells. Exposure to fMLP resulted in a decrease in the electrophoretic mobility of cPLA2, a finding consistent with cPLA2 phosphorylation, and stimulated the translocation of cPLA2 from cytosolic to microsomal and nuclear compartments. The role of cPLA2 was further evaluated with the cPLA2 inhibitor methyl arachidonyl fluorophosphonate, which attenuated cPLA2 activity in vitro and decreased fMLP-stimulated AA mass release by intact neutrophils, but had no effect on neutrophil sPLA2 activity. Inhibition of calcium-independent PLA2 with haloenol lactone suicide substrate had no effect on neutrophil cPLA2 activity or AA mass release. These results indicate a role for cPLA2 and an intracellular or cell-associated sPLA2 in the release of AA from fMLP-stimulated human neutrophils.
This article has been cited by other articles:
![]() |
S. Brechard and E. J. Tschirhart Regulation of superoxide production in neutrophils: role of calcium influx J. Leukoc. Biol., November 1, 2008; 84(5): 1223 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ruiperez, J. Casas, M. A. Balboa, and J. Balsinde Group V Phospholipase A2-Derived Lysophosphatidylcholine Mediates Cyclooxygenase-2 Induction in Lipopolysaccharide-Stimulated Macrophages J. Immunol., July 1, 2007; 179(1): 631 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Frasch, K. Zemski-Berry, R. C. Murphy, N. Borregaard, P. M. Henson, and D. L. Bratton Lysophospholipids of Different Classes Mobilize Neutrophil Secretory Vesicles and Induce Redundant Signaling through G2A J. Immunol., May 15, 2007; 178(10): 6540 - 6548. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Pessach, Z. Shmelzer, T. L. Leto, M. C. Dinauer, and R. Levy The C-terminal flavin domain of gp91phox bound to plasma membranes of granulocyte-like X-CGD PLB-985 cells is sufficient to anchor cytosolic oxidase components and support NADPH oxidase-associated diaphorase activity independent of cytosolic phospholipase A2 regulation J. Leukoc. Biol., September 1, 2006; 80(3): 630 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Iizuka, T. Yokomizo, K. Terawaki, M. Komine, K. Tamaki, and T. Shimizu Characterization of a Mouse Second Leukotriene B4 Receptor, mBLT2: BLT2-DEPENDENT ERK ACTIVATION AND CELL MIGRATION OF PRIMARY MOUSE KERATINOCYTES J. Biol. Chem., July 1, 2005; 280(26): 24816 - 24823. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Rubin, G. P. Downey, A. Koh, N. Degousee, F. Ghomashchi, L. Nallan, E. Stefanski, D. W. Harkin, C. Sun, B. P. Smart, et al. Cytosolic Phospholipase A2-{alpha} Is Necessary for Platelet-activating Factor Biosynthesis, Efficient Neutrophil-mediated Bacterial Killing, and the Innate Immune Response to Pulmonary Infection: cPLA2-{alpha} DOES NOT REGULATE NEUTROPHIL NADPH OXIDASE ACTIVITY J. Biol. Chem., March 4, 2005; 280(9): 7519 - 7529. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W.M Niessen, P. A.J Krijnen, C. A Visser, C. J.L.M Meijer, and C Erik Hack Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovasc Res, October 15, 2003; 60(1): 68 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K.M. Wong, A. I. Pettit, P. A. Quinn, S. C. Jennings, J. E. Davies, and L. L. Ng Advanced Glycation End Products Stimulate an Enhanced Neutrophil Respiratory Burst Mediated Through the Activation of Cytosolic Phospholipase A2 and Generation of Arachidonic Acid Circulation, October 14, 2003; 108(15): 1858 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Bae, J. C. Park, R. He, R. D. Ye, J.-Y. Kwak, P.-G. Suh, and S. Ho Ryu Differential Signaling of Formyl Peptide Receptor-Like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or Lipoxin A4 in Human Neutrophils Mol. Pharmacol., September 1, 2003; 64(3): 721 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Shmelzer, N. Haddad, E. Admon, I. Pessach, T. L. Leto, Z. Eitan-Hazan, M. Hershfinkel, and R. Levy Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes J. Cell Biol., August 18, 2003; 162(4): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Kim, K. P. Kim, S. K. Han, N. M. Munoz, X. Zhu, H. Sano, A. R. Leff, and W. Cho Group V Phospholipase A2 Induces Leukotriene Biosynthesis in Human Neutrophils through the Activation of Group IVA Phospholipase A2 J. Biol. Chem., September 20, 2002; 277(39): 36479 - 36488. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Degousee, F. Ghomashchi, E. Stefanski, A. Singer, B. P. Smart, N. Borregaard, R. Reithmeier, T. F. Lindsay, C. Lichtenberger, W. Reinisch, et al. Groups IV, V, and X Phospholipases A2s in Human Neutrophils. ROLE IN EICOSANOID PRODUCTION AND GRAM-NEGATIVE BACTERIAL PHOSPHOLIPID HYDROLYSIS J. Biol. Chem., February 8, 2002; 277(7): 5061 - 5073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Teixeira, C. Bernard, E. Ferrary, and D. Butlen Purine and pyrimidine nucleotide-sensitive phospholipase A2 in ampulla from frog semicircular canal Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R519 - R526. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |